http://www.epizyme.com
Epizyme, Inc. Company Intro
Epizyme is a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer
Industry
Healthcare
Epizyme, Inc. Headquaters
400 Technology Square
Cambridge,02139
United States
Epizyme, Inc. Share price
21 Oct 2020 01:33 GMT
$13.85
0.16 (1.17 %)
Epizyme, Inc. Market cap
$1.397 B
WMC RANKING
2020
Epizyme, Inc. # 131
BiotechnologyLatest Epizyme, Inc. News
21 Oct 2020
Rhabdomyosarcoma Drug Market SWOT Analysis By 2020 ...
Bellicum Pharmaceuticals Inc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Co, Celgene Corp, Eisai Co Ltd, Epizyme Inc, Exelixis Inc, Iproteos SL, Ipsen ...
21 Oct 2020
Epizyme Target of Unusually High Options Trading (NASDAQ ...
90.93% of the stock is owned by institutional investors and hedge funds. Epizyme Company Profile. Epizyme, Inc, a late-stage biopharmaceutical company, ...
21 Oct 2020
Epigenetics Market Size Share Analysis and System Production (2020-2025)
New England Biolabs, Inc.• Epizyme Inc.• Thermo Fisher Scientific, Inc.• Active Motif. Diagenode, Inc. • Others. This report focuses on Global Epigenetics Market ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Epizyme, Inc. | 0.31 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.15 | 100 | 19 | 0 | 0 | 98.93 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.89 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.06 | 100 | 0 | 0 | 90.93 |
Epizyme, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Epizyme, Inc. | $17,263 | $214,150 | $-191,893 | $1.397B | 131 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $27.177B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.881B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥20.867B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.532B | 4 |